ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer's Disease

被引：0
|
作者：
Seleri, Sheila [1 ]
Brangman, Sharon [2 ]
Henderson, J. Neil [3 ]
Parker, Monica [4 ]
Monroe, Stephanie [5 ]
Mintzer, Jacobo [6 ]
Wise-Brown, Alexandria [1 ]
Grundman, Michael [7 ]
Smith, Janice [8 ]
Doody, Rachelle [8 ]
Lin, Helen [1 ]
Assman, Beverly [1 ]
Rippon, Gregory [1 ]
机构：
[1] Genentech Inc, Roche Grp, San Francisco, CA USA
[2] SUNY Upstate Med Univ, Syracuse, NY USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Emory Univ, Sch Med, Goizueta Alzheimers Dis Res Ctr, Atlanta, GA USA
[5] UsAgainstAlzheimers, Washington, DC USA
[6] Med Univ South Carolina, Charleston, SC USA
[7] Global R&D Partners LLC, San Diego, CA USA
[8] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203813
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S26.006
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer′s Disease Study (LEADS)
    Cho, Hanna
    Mundada, Nidhi S.
    Apostolova, Liana G.
    Carrillo, Maria C.
    Shankar, Ranjani
    Amuiri, Alinda N.
    Zeltzer, Ehud
    Windon, Charles C.
    Soleimani-Meigooni, David N.
    Tanner, Jeremy A.
    Heath, Courtney Lawhn
    Lesman-Segev, Orit H.
    Aisen, Paul
    Eloyan, Ani
    Lee, Hye Sun
    Hammers, Dustin B.
    Kirby, Kala
    Dage, Jeffrey L.
    Fagan, Anne
    Foroud, Tatiana
    Grinberg, Lea T.
    Jack, Clifford R.
    Kramer, Joel
    Kukull, Walter A.
    Murray, Melissa E.
    Nudelman, Kelly
    Toga, Arthur
    Vemuri, Prashanthi
    Atri, Alireza
    Day, Gregory S.
    Duara, Ranjan
    Graff-Radford, Neill R.
    Honig, Lawrence S.
    Jones, David T.
    Masdeu, Joseph
    Mendez, Mario
    Musiek, Erik
    Onyike, Chiadi U.
    Riddle, Meghan
    Rogalski, Emily J.
    Salloway, Stephen
    Sha, Sharon
    Turner, Raymond Scott
    Wingo, Thomas S.
    Wolk, David A.
    Koeppe, Robert
    Iaccarino, Leonardo
    Dickerson, Bradford C.
    La Joie, Renaud
    Rabinovici, Gil D.
    ALZHEIMERS & DEMENTIA, 2023, 19 : S98 - S114
  • [32] TRAILBLAZER-ALZ 4: Topline study results directly comparing donanemab to aducanumab on amyloid lowering in early, symptomatic Alzheimer's disease
    Salloway, Stephen
    Lee, Elly
    Papka, Michelle
    Pain, Andrew
    Oru, Ena
    Ferguson, Margaret
    Wang, Hong
    Case, Michael
    Lu, Ming
    Collins, Emily
    Brooks, Dawn
    Sims, John
    NEUROLOGY, 2023, 100 (17)
  • [33] TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease
    Salloway, Stephen
    Lee, Elly
    Papka, Michelle
    Pain, Andrew
    Oru, Ena
    Ferguson, Margaret B.
    Wang, Hong
    Case, Michael
    Lu, Ming
    Collins, Emily C.
    Brooks, Dawn A.
    Sims, John
    BJPSYCH OPEN, 2023, 9 : S67 - S67
  • [34] TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease
    Salloway, Stephen
    Lee, Elly
    Papka, Michelle
    Pain, Andrew
    Oru, Ena
    Ferguson, Margaret B.
    Wang, Hong
    Case, Michael
    Lu, Ming
    Collins, Emily C.
    Brooks, Dawn A.
    Sims, John
    BJPSYCH OPEN, 2023, 9 : S67 - S67
  • [35] Design of a Non-Interventional Study to Assess Neurologists' Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease
    Saposnik, Gustavo
    Sanchez-Benavidez, Gonzalo
    Garcia-Arcelay, Elena
    Franco-Macias, Emilio
    Bensi, Catalina
    Carmelingo, Sebastian
    Allegri, Ricardo F.
    Perez-Martinez, David A.
    Maurino, Jorge
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 995 - 1006
  • [36] Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease
    Gustavo Saposnik
    Gonzalo Sánchez-Benavidez
    Elena García-Arcelay
    Emilio Franco-Macías
    Catalina Bensi
    Sebastián Carmelingo
    Ricardo F. Allegri
    David A. Pérez-Martínez
    Jorge Maurino
    Neurology and Therapy, 2023, 12 : 995 - 1006
  • [37] Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic
    Bader, Ilse
    Groot, Colin
    Tan, H. Stevie
    Milongo, Jean-Marie A.
    den Haan, Jurre
    Verberk, Inge M. W.
    Yong, Keir
    Orellina, Julie
    Campbell, Shannon
    Wilson, David
    van Harten, Argonde C.
    Kok, Pauline H. B.
    van der Flier, Wiesje M.
    Pijnenburg, Yolande A. L.
    Barkhof, Frederik
    van de Giessen, Elsmarieke
    Teunissen, Charlotte E.
    Bouwman, Femke H.
    Ossenkoppele, Rik
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [38] The Traveling Salesman Problem as a new screening test in early Alzheimer's disease:: an exploratory study.: Visual problem-solving in AD
    De Vreese, LP
    Pradelli, S
    Massini, G
    Buscema, M
    Savarè, R
    Grossi, E
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 17 (06) : 458 - 464
  • [39] Design, Synthesis and Molecular Modeling Study of Radiotracers Based on Tacrine and Its Derivatives for Study on Alzheimer's Disease and Its Early Diagnosis
    Kozminski, Przemyslaw
    Gniazdowska, Ewa
    APPLIED SCIENCES-BASEL, 2024, 14 (07):
  • [40] The Traveling Salesman Problem as a new screening test in early Alzheimer’s disease: an exploratory study. Visual Problem-solving in AD
    Luc Pieter De Vreese
    Samantha Pradelli
    Giulia Massini
    Massimo Buscema
    Rita Savarè
    Enzo Grossi
    Aging Clinical and Experimental Research, 2005, 17 : 458 - 464
12345